Long-term safety and efficacy of deferasirox in patients with myelodysplastic syndrome, aplastic anemia and other rare anemia in Taiwan

BOR-SHENG KOChang M.-C.Chiou T.-J.Chang T.-K.Chen Y.-C.Lin S.-F.Chang C.-S.Lu Y.-C.Yeh S.-P.Chen T.-Y.Hwang W.-S.2022-09-132022-09-1320191024-5332https://www.scopus.com/inward/record.uri?eid=2-s2.0-85058734002&doi=10.1080%2f16078454.2018.1557860&partnerID=40&md5=5526f5d11ffd9c330a8cdec29905ae62https://scholars.lib.ntu.edu.tw/handle/123456789/619690[SDGs]SDG3Long-term safety and efficacy of deferasirox in patients with myelodysplastic syndrome, aplastic anemia and other rare anemia in Taiwanjournal article10.1080/16078454.2018.1557860305585222-s2.0-85058734002